These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 4810089)

  • 1. The administration of 5-fluorouracil by mouth.
    Bruckner HW; Creasey WA
    Cancer; 1974 Jan; 33(1):14-8. PubMed ID: 4810089
    [No Abstract]   [Full Text] [Related]  

  • 2. 5-Fluorouracil in the treatment of gastrointestinal neoplasia.
    Kaufman S
    N Engl J Med; 1973 Jan; 288(4):199-201. PubMed ID: 4264581
    [No Abstract]   [Full Text] [Related]  

  • 3. 5-fluorouracil given once weekly: comparison of intravenous and oral administration.
    Bateman JR; Pugh RP; Cassidy FR; Marshall GJ; Irwin LE
    Cancer; 1971 Oct; 28(4):907-13. PubMed ID: 5111743
    [No Abstract]   [Full Text] [Related]  

  • 4. Combination therapy of solid tumors using 1,3-bis(2-chloroethyl)-1-nitrosourea (NCNU), vincristine, methotrexate, and 5-fluorouracil.
    Omura GA; Roberts GA
    Cancer; 1973 Jun; 31(6):1374-81. PubMed ID: 4709952
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical management of advanced gastrointestinal cancer.
    Moertel C
    Semin Drug Treat; 1973; 3(1):55-68. PubMed ID: 4351814
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical pharmacology of oral and intravenous 5-fluorouracil (NSC-19893).
    Cohen JL; Irwin LE; Marshall GJ; Darvey H; Bateman JR
    Cancer Chemother Rep; 1974; 58(5 Pt 1):723-31. PubMed ID: 4609602
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemotherapy of metastatic gastrointestinal neoplasms with 5-fluorouracil and streptozotocin.
    Seligman M; Bukowski RM; Groppe CW; Weick JK; Hewlett JS; Greenstreet RL
    Cancer Treat Rep; 1977 Oct; 61(7):1375-7. PubMed ID: 201379
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolic studies of 5-fluorouracil. II. Influence of the route of administration on the dynamics of distribution in man.
    Douglass HO; Mittelman A
    Cancer; 1974 Dec; 34(6):1878-81. PubMed ID: 4373162
    [No Abstract]   [Full Text] [Related]  

  • 9. Distribution of 5-fluorouracil to body tissues compared after intraluminal, intravenous, and intramural administration in gastrointestinal cancer.
    Shukla HS; Hughes LE; Davis PW; Whitehead RH; Leach KG
    Am J Surg; 1977 Mar; 133(3):346-50. PubMed ID: 848665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [5-fluorouracil effectiveness and toxicity in the treatment of digestive trac.t neoplasms as a function of the mode of administration].
    Zelechowska JA; Madej G
    Nowotwory; 1976; 26(1):29-36. PubMed ID: 1257062
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of metastatic colorectal carcinoma with 5-fluorouracil by mouth.
    Lahiri SR; Boileau G; Hall TC
    Cancer; 1971 Oct; 28(4):902-6. PubMed ID: 5111742
    [No Abstract]   [Full Text] [Related]  

  • 12. A double-blind comparison of intensive course 5-flourouracil by oral vs. intravenous route in the treatment of colorectal carcinoma.
    Hahn RG; Moertel CG; Schutt AJ; Bruckner HW
    Cancer; 1975 Apr; 35(4):1031-5. PubMed ID: 1090358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of cancer with weekly intravenous 5-fluorouracil.
    Jacobs EM; Luce JK; Wood DA
    Cancer; 1968 Dec; 22(6):1233-8. PubMed ID: 5705785
    [No Abstract]   [Full Text] [Related]  

  • 14. Combination chemotherapy in gastrointestinal cancer.
    Reitemeier RJ; Moertel CG; Hahn RG
    Cancer Res; 1970 May; 30(5):1425-8. PubMed ID: 4246651
    [No Abstract]   [Full Text] [Related]  

  • 15. Serial liver scanning. Metastatic disease.
    Tully TE; Shafer RB
    Minn Med; 1974 Feb; 57(2):84-6. PubMed ID: 4813615
    [No Abstract]   [Full Text] [Related]  

  • 16. Combined 5-fluorouracil and hydroxyurea therapy for gastrointestinal cancer.
    Lokich JJ; Pitman SW; Skarin AT
    Oncology; 1975; 32(1):34-7. PubMed ID: 1208028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of 5-fluorouracil in plasma by GC/MS using an internal standard. Applications to pharmacokinetics.
    Cano JP; Rigault JP; Aubert C; Carcassonne Y; Seitz JF
    Bull Cancer; 1979; 66(1):67-74. PubMed ID: 420949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of parenteral 5-fluorouracil in solid tumours. A preliminary report.
    Chakravorty RC; Sarkar SK; Mukerji B
    J Indian Med Assoc; 1969 Jan; 52(1):27-31. PubMed ID: 5801452
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of cancer with weekly intravenous 5-fluorouracil. Study by the Western Cooperative Cancer Chemotherapy Group (WCCCG).
    Jacobs EM; Reeves WJ; Wood DA; Pugh R; Braunwald J; Bateman JR
    Cancer; 1971 Jun; 27(6):1302-5. PubMed ID: 5088208
    [No Abstract]   [Full Text] [Related]  

  • 20. The treatment of metastatic carcinoma of the liver by the percutaneous selective hepatic artery infusion of 5-fluorouracil.
    Tandon RN; Bunnell IL; Cooper RG
    Surgery; 1973 Jan; 73(1):118-21. PubMed ID: 4683272
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.